As a partner in the firm's Intellectual Property group, Chris focuses his practice on biotechnology patent preparation and prosecution across RNA interference (RNAi), antibody, microbiology, virology, cell biology, and genomic technologies. He also provides strategic IP counsel to academic and biotech industry clients on domestic and international IP portfolio management.
Partial Data by Infogroup (c) 2024. All rights reserved.